SEC Form 4 · accession 0001123292-18-000869
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen Sabzevari
Officer — President, Precigen, Inc.
Period of report
Jul 17, 2018
Accepted (ET)
Jul 19, 2018 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 17, 2018 | M | 25,000 | — | A | 25,000 | D | |
| Common Stock | Jul 18, 2018 | S | 8,402 | $14.54 | D | 16,598 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jul 17, 2018 | M | 25,000 | D | — | — | Common Stock | 25,000 | 75,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- F2This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- F3The restricted stock units were granted on March 28, 2018, and the remaining restricted stock units vest in three equal annual installments on each of July 17, 2019, 2020 and 2021.